This presentation will include information on the current state of gene therapy in neuromuscular disease. It will include successes and failures using spinal muscular atrophy, Duchenne muscular dystrophy and XL-myotubular myopathy as examples.

Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.

Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.